DTR
Dateline Resources Limited
🇦🇺 ASX
⛏️ MINING
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 4.00%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
1
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Dateline Resources Ltd. engages in the exploration, acquisition, and evaluation of gold properties and other minerals. The company is headquartered in Sydney, New South Wales. The company went IPO on 2011-06-23. The firm owns 100% of the Colosseum Gold- rare-earth elements (REE) Project in California. The Colosseum Mine is located in the Walker Lane Trend in East San Bernardino County, California. The Company’s Colosseum is located less than 10 kilometers north of the Mountain Rare Earth mine. Its segments include Australia, the USA and Fiji. The Company’s Argos Strontium Project is located approximately 100 kilometers from its flagship Colosseum Gold and Rare Earths project in San Bernardino, California. The firm's Nagasauva target is located 1.8km south of the Udu mine. Its Korobotoni target is approximately 7.2km south-west of the Udu mine. Its Nukasa target is approximately 8.5km south-west of the Udu Mine.
📈 Performance
Price History
-80.00%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.00
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in DTR
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in DTR
N/A
DTR investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in DTR also invest in...
VBLD.AX was created on 2018-10-19 by Vanguard. The fund's investment portfolio concentrates primarily on theme equity. Vanguard Global Infrastructure Index ETF seeks to track the return of the FTSE Developed Core Infrastructure Index (with net dividends reinvested) in Australian dollars, before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
1.67%
📊 Share price
$72.00 AUD
🏭 INDUSTRIALS
🌏 GLOBAL
🔋 UTILITIES
FOOD.AX was created on 2016-08-02 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. The Investment objective of the Betashares Global Agriculture Companies ETF - Currency Hedged is to provide an investment returns that aims to track the performance of the Nasdaq Global ex - Australia company hedged AUD Index.
🙌 Performance (5Yr p.a)
3.05%
📊 Share price
$6.43 AUD
🌏 GLOBAL
4DS Memory Ltd. operates as a semiconductor development company. The company is headquartered in Perth, Western Australia. The company went IPO on 2010-12-09. The firm is engaged in the development of a non-volatile memory technology, pioneering Interface Switching resistive random-access memory (ReRAM) for gigabyte storage in mobile and cloud. Interface Switching ReRAM, an area-based ReRAM technology positioned for Storage Class Memory in mobile devices and cloud data centers. The company owns a patented Internet protocol (IP) portfolio, comprising 34 United States patents granted, which has been developed in-house to create high-density storage class memory. The 4DS Interface Switching ReRAM meets the essential requirements for Storage Class Memory close to DRAM. The firm also collaborates with imec, a research and hub in nanoelectronics and digital technologies.
🙌 Performance (5Yr p.a)
-8.36%
📊 Share price
$0.03 AUD
🤖 TECHNOLOGY
AdAlta Ltd. operates as a biotechnology company, discovers, develops, and commercializes protein based therapeutics. The firm uses its i-body platform to discover and develop protein therapeutics addressing drug targets that are challenging for other technologies. The firm's first-in-class lead asset, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases, for which current therapies are sub-optimal. AD-214 is an Fc-Fusion protein that contains two AD-114 i-body molecules at the front end, that bind with high affinity to the human target, CXCR4. The company is also engaged in developing i-body enabled Chimeric antigen receptor T cell (CAR-T) cells. The company co-develops i-bodies as diagnostic imaging agents (i-PET imaging) against Granzyme B, a biomarker of response to immuno-oncology drugs.
🙌 Performance (5Yr p.a)
-16.15%
📊 Share price
$0.01 AUD
🧬 BIOTECHNOLOGY
IXI.AX was created on 2006-09-12 by iShares. The fund's investment portfolio concentrates primarily on consumer staples equity. The fund aims to provide investors with the performance of the S&P Global 1200 Consumer Staples Sector Index, before fees and expenses. The index is designed to measure the performance of global consumer staples companies and may include large-, mid- or smallcapitalisation stocks.
🙌 Performance (5Yr p.a)
3.78%
📊 Share price
$98.86 AUD
🌏 GLOBAL
Want more shares? Try these...
